Peptide purity testing is the set of analytical measurements that establish what is actually in a vial of synthetic peptide. In practice it means two orthogonal techniques: reverse-phase HPLC, which reports how much of the UV-absorbing material is the target compound, and mass spectrometry, which confirms that the compound is the right one. This guide explains how each works, why “99% pure” and “99% peptide” are different statements, and how to read a certificate of analysis critically.
Key takeaways
- Purity and content are different numbers. HPLC purity is the proportion of detected peptide material that is the target; net peptide content is the proportion of the powder’s mass that is peptide at all.
- A vial labelled “99% purity” can still be 70–80% peptide by mass, with the balance made up of counter-ions, bound water and residual salts.
- Reverse-phase HPLC separates by hydrophobicity on a C18 column using a water/acetonitrile gradient with an ion-pairing acid, usually trifluoroacetic acid, and detects at 214–220 nm where the peptide bond absorbs.
- Purity is calculated by area normalisation — the main peak’s area divided by total peak area — which means it measures relative, not absolute, composition.
- Mass spectrometry answers a different question: identity. Electrospray ionisation produces a charge-state envelope that is deconvoluted to a neutral mass and compared with the calculated mass.
- Neither technique alone is sufficient. HPLC cannot distinguish a co-eluting isomer; MS cannot quantify reliably across species with different ionisation efficiency.
- ICH guidance recognises that absolute purity of a biological product is method-dependent and should be assessed by a combination of procedures rather than one number.
Why peptide purity testing matters
Peptide purity testing exists because solid-phase synthesis is an efficient process that is never perfect. Each residue is added in a repeated deprotect–couple–wash cycle, and even a very high per-step efficiency compounds into a substantial fraction of incorrect chains over a long sequence.
The arithmetic is unforgiving. At 99% coupling efficiency per step, a 26-residue peptide comes off the resin at roughly 77% crude purity. Drop the efficiency to 95% and the same sequence yields around 25% target compound. Everything else is deletion sequences, truncations and side-reaction products that have to be removed by purification.
For a researcher, this matters in three concrete ways. An impure preparation shifts the effective concentration of the compound you think you are studying. Structurally related impurities may themselves be biologically active at the same receptor. And batch-to-batch variation in impurity profile makes results non-reproducible for reasons that have nothing to do with the experiment.
Where peptide impurities come from
Impurities in a synthetic peptide fall into two families: product-related species that are chemically similar to the target, and process-related material carried through from synthesis and purification. ICH Q6B draws this same distinction for biotechnological products, and it is the most useful way to think about a chromatogram.
| Impurity | Origin | Mass difference | How it appears |
|---|---|---|---|
| Deletion sequence | Incomplete coupling at one cycle | Minus one residue | Separate HPLC peak; distinct MS mass |
| Truncated sequence | Chain termination mid-synthesis | Substantially lower | Usually earlier-eluting peak |
| Incomplete side-chain deprotection | Protecting group survives cleavage | Plus the protecting group mass | Later-eluting, more hydrophobic peak |
| Oxidised methionine or cysteine | Air exposure during work-up or storage | Plus 16 Da per oxygen | Earlier-eluting shoulder; +16 in MS |
| Deamidated Asn or Gln | Hydrolysis, favoured at alkaline pH | Plus 1 Da | Often a poorly resolved shoulder |
| Disulfide scrambling | Wrong pairing in multi-Cys peptides | None — isomeric | May co-elute; MS cannot distinguish |
| Racemised residue | Activation during coupling | None — isomeric | Sometimes resolves; MS blind to it |
| Counter-ion salt | TFA or acetate from cleavage and HPLC | n/a | Not seen by UV; reduces net content |
| Bound water | Hygroscopic lyophilised cake | n/a | Not seen by UV; reduces net content |
How RP-HPLC measures purity
Reverse-phase high-performance liquid chromatography separates peptides by hydrophobicity. The stationary phase is a hydrophobic ligand — most often an octadecyl (C18) chain bonded to silica — and the mobile phase is a mixture of water and an organic modifier, typically acetonitrile, whose proportion is increased over the run as a gradient.
Hydrophilic species interact weakly with the C18 surface and elute early. Hydrophobic species are retained and need a higher organic proportion to release. Because a single residue’s difference changes a peptide’s overall hydrophobicity, closely related impurities such as deletion sequences usually resolve from the main peak.
The role of trifluoroacetic acid
Peptides carry charged groups, and charged species give poor peak shape on a reverse-phase column. Trifluoroacetic acid is added to both mobile phases at low concentration as an ion-pairing agent: it neutralises basic side chains, sharpens peaks and improves resolution. TFA is also the acid used to cleave Fmoc-strategy peptides from the resin, which is why it so often ends up as the peptide’s counter-ion.
Detection wavelength
UV detection for peptides is usually at 214–220 nm, where the amide bond of the backbone itself absorbs. This is deliberate: every peptide has backbone amide bonds regardless of sequence, so detection at this wavelength is broadly quantitative across species. Detection at 280 nm, where tryptophan and tyrosine absorb, is more selective but blind to peptides lacking aromatic residues.
Reading a chromatogram
A chromatogram on a certificate of analysis should show a baseline, a dominant main peak and any resolved impurity peaks, with a retention time and integrated area for each. Purity is reported as the main peak’s area as a percentage of total integrated area.
Four things to check
- Is the whole run shown? A chromatogram cropped around the main peak hides late-eluting hydrophobic impurities. The trace should run to the end of the gradient and a wash step.
- Is the baseline flat and the peak symmetric? A leading or tailing peak suggests column overload, a secondary interaction or a partly resolved impurity hiding in the shoulder.
- Is the integration honest? Look at where the integration boundaries sit. Narrow boundaries around a broad main peak inflate the purity figure by excluding shoulder material.
- Does the retention time match the method? The COA should state column, gradient, flow rate and wavelength. Without the method, a retention time is uninterpretable and cannot be reproduced.
How mass spectrometry confirms identity
Mass spectrometry answers a question HPLC cannot: is this the right molecule? The instrument ionises the sample, separates ions by mass-to-charge ratio and records their abundance. For peptides, two ionisation methods dominate.
Electrospray ionisation
Electrospray ionisation, introduced for large biomolecules by Fenn and colleagues in 1989, disperses a liquid sample into charged droplets by applying a high voltage. As solvent evaporates the droplets shrink and divide until bare ions remain. Crucially, peptides and proteins pick up multiple protons, producing a series of ions of the same molecule at different charge states — the charge-state envelope.
Because charge appears in the denominator of m/z, multiple charging brings a 4,700 Da peptide into a mass range that a modest analyser can measure. Software then deconvolutes the envelope: each observed m/z with its inferred charge yields an estimate of the neutral mass, and the estimates are combined into a single deconvoluted mass. ESI is also the natural partner for liquid chromatography, giving the LC-MS combination used for most peptide QC.
MALDI time-of-flight
Matrix-assisted laser desorption/ionisation, developed by Karas and Hillenkamp in the late 1980s, co-crystallises the peptide with a UV-absorbing organic matrix and fires a pulsed laser at the spot. The matrix absorbs the energy and carries the peptide into the gas phase. MALDI produces predominantly singly charged ions, which makes spectra simple to read, and it pairs naturally with a time-of-flight analyser.
Average mass or monoisotopic mass?
Two mass values exist for any peptide. The monoisotopic mass uses the lightest isotope of each element and is what a high-resolution instrument reports for a resolved isotope cluster. The average mass weights each element by its natural isotopic abundance and is what a low-resolution instrument or a deconvolution of an unresolved envelope reports.
For a peptide of a few thousand daltons the two differ by several units, so comparing an observed average mass against a calculated monoisotopic mass will look like a failure when nothing is wrong. A COA should say which convention it uses.
Purity vs net peptide content: what 99% really means
This is the single most misunderstood point in peptide specification. HPLC purity answers: of the peptide material the detector sees, what fraction is the target? Net peptide content answers: of the mass in the vial, what fraction is peptide at all?
A lyophilised vial contains the peptide, its counter-ions, water absorbed by the hygroscopic cake, and any residual salts from purification. Counter-ions come from the acids used in synthesis and chromatography — trifluoroacetate or acetate — and pair with every basic side chain in the sequence. None of this non-peptide mass absorbs UV at 214 nm, so none of it appears in an HPLC purity figure.
Net peptide content is measured differently. The reference method is amino acid analysis: the sample is hydrolysed in 6 M hydrochloric acid at around 110 °C for 24 hours, the released amino acids are derivatised and separated chromatographically, and the quantity recovered is compared against standards. Elemental nitrogen analysis and quantitative UV against a known extinction coefficient are also used.
Amino acid analysis has its own limits worth knowing: the harsh hydrolysis destroys or partially destroys serine, threonine, tyrosine, tryptophan, glutamine and cysteine, so those residues are either corrected for by extrapolation or excluded from the calculation.
Purity grades and what they mean for research
Purity requirements should be set by the application, not by a preference for the largest number. Higher grades cost disproportionately more because the final percentage points of purification lose yield fastest.
| Grade | Typical use | What the remaining fraction is | Notes |
|---|---|---|---|
| Crude (< 70%) | Screening libraries, epitope mapping | Deletion and truncated sequences | Not appropriate for quantitative assays |
| > 85% | Antibody production, qualitative work | Related sequences, some oxidation | Adequate where the readout is not concentration-sensitive |
| > 95% | Most cell-based and biochemical assays | Minor related species | The common working standard for research material |
| > 98% | Receptor pharmacology, structural work | Trace related species | Worth specifying where an impurity may be active |
| > 99% | Reference standards, analytical calibration | Near-baseline | Diminishing returns; verify content as well |
What each test cannot tell you
The reason a credible certificate carries several tests is that each has a blind spot. ICH Q6B makes this explicit for biological products: absolute purity is difficult to determine, results are method-dependent, and purity should be assessed using a combination of procedures.
| Test | Question answered | Blind to |
|---|---|---|
| RP-HPLC | How much of the detected material is the target? | Co-eluting isomers, racemisation, non-UV-absorbing salts and water |
| Mass spectrometry | Is the molecule the right mass? | Isomers of identical mass, quantitation across species, counter-ions |
| Amino acid analysis | How much peptide is in the powder by mass? | Sequence order; partially destroys six residue types in hydrolysis |
| Water content (Karl Fischer) | How much bound and free water? | Everything else |
| Appearance | Is the cake intact and correctly coloured? | Anything chemical |
| Sequence confirmation (MS/MS or Edman) | Is the residue order correct? | Quantity and bulk purity |
Reading a certificate of analysis critically
A certificate of analysis is only useful if it is traceable to a specific batch of the specific material you received. The checks below take about a minute and eliminate most of the ways a document can be misleading.
- Match the batch number. The batch on the certificate must match the batch printed on the vial. A generic “typical” certificate for a product line is not batch data.
- Check the date. Analysis should postdate manufacture. A certificate older than the batch is a copy-paste error at best.
- Look for the method conditions. Column, gradient, flow rate, wavelength, injection volume. Without these, the purity number cannot be reproduced or challenged.
- Confirm identity independently of purity. An MS result with an observed mass matching the calculated mass, stated as average or monoisotopic.
- Find the content figure. Net peptide content or, failing that, water content and counter-ion. If none is given, treat the label mass as gross mass.
- Note who performed the testing. Third-party analysis carries more weight than an in-house figure with no laboratory named.
GenoPept publishes per-batch third-party certificates covering HPLC purity and mass spectrometry identity; they are viewable at our COA page, and our companion guide covers how to read a peptide certificate of analysis field by field.
Batch-tested peptides in the GenoPept store
Frequently asked questions
What does 99% peptide purity actually mean?
It means that on a reverse-phase HPLC chromatogram, the main peak accounted for 99% of the total integrated peak area at the detection wavelength. It is a relative measure of the peptide-related material the detector could see. It says nothing about how much of the vial’s mass is peptide, because counter-ions, water and salts do not absorb UV and are excluded from the calculation.
What is the difference between peptide purity and net peptide content?
Purity is chromatographic: the proportion of detected peptide material that is the target compound. Net peptide content is gravimetric: the proportion of the powder’s total mass that is peptide rather than counter-ions, water or residual salts. A vial can be 99% pure and around 75% peptide by mass at the same time, which is why both figures belong on a certificate of analysis.
Why is trifluoroacetic acid used in peptide HPLC?
TFA acts as an ion-pairing agent. Peptides carry charged side chains that give broad, tailing peaks on a reverse-phase column; TFA neutralises basic groups and sharpens peak shape, improving resolution between the target and closely related impurities. TFA is also the acid used to cleave Fmoc-strategy peptides from the resin, which is why it frequently persists as the peptide’s counter-ion.
Why does mass spectrometry show several peaks for one peptide?
Electrospray ionisation adds multiple protons to a peptide, so the same molecule appears at several mass-to-charge ratios — the charge-state envelope. Deconvolution software converts that series into a single neutral mass. MALDI, by contrast, produces predominantly singly charged ions and gives a simpler spectrum, which is one reason it is often used for quick identity confirmation.
Can HPLC and mass spectrometry miss an impurity?
Yes, and in different ways. HPLC cannot resolve species with identical hydrophobicity, so a racemised residue or a scrambled disulfide isomer may co-elute with the target. Mass spectrometry cannot distinguish isomers at all, since they share a mass, and its response varies between species so it is a poor quantitative tool. This is why ICH guidance recommends assessing purity with a combination of methods.
What purity grade do I need for laboratory research?
It depends on the readout. Screening and qualitative work tolerates 85% and above. Most cell-based and biochemical assays are run on material above 95%. Receptor pharmacology and structural studies, where a related impurity might itself be active, justify 98% or higher. Above 99% the extra cost usually buys more benefit as a reference standard than as an assay reagent.
How is net peptide content measured?
The reference method is amino acid analysis: the sample is hydrolysed in 6 M hydrochloric acid at around 110 °C for roughly 24 hours, the liberated amino acids are derivatised and separated chromatographically, and the recovered quantity is compared with standards. Elemental nitrogen analysis and quantitative UV absorbance against a known extinction coefficient are alternative approaches.
What should a good certificate of analysis include?
A batch number that matches the vial, the analysis date, appearance, an HPLC chromatogram with full method conditions and an integration table, a mass spectrum with the observed and calculated masses and whether they are average or monoisotopic, water content, and ideally net peptide content. The testing laboratory should be named. A bare percentage with no supporting trace is an assertion, not data.
References
- Mant CT, Chen Y, Yan Z, et al. HPLC analysis and purification of peptides. Methods in Molecular Biology. 2007;386:3–55. Springer
- Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science. 1989;246(4926):64–71. PubMed
- Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Analytical Chemistry. 1988;60(20):2299–2301. PubMed
- Merrifield RB. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. Journal of the American Chemical Society. 1963;85(14):2149–2154. DOI
- International Council for Harmonisation. ICH Q6B: Specifications — Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. Adopted 10 March 1999. ICH
Peptides with real batch analytics
GenoPept supplies lyophilised research peptides with a per-batch third-party certificate of analysis covering HPLC purity and mass spectrometry identity, dispatched from the UK, strictly for laboratory research.